News Room

This page is designed to provide you with quick and easy access to key information about King Pharmaceuticals. Here you will find an archive of King news releases, information about our company and leaders and how to reach us.
If you cannot find what you’re looking for, please contact our Corporate Affairs department at 908-429-8350.

07/07/2009	King and Pain Therapeutics Announce REMOXY® NDA Update
07/02/2009	Acura and King Receive FDA Complete Response Letter Regarding Acurox®
06/25/2009	Alpharma's Reach Teach Learn Initiative Targets Youth and Consumer Awareness
06/25/2009	King Pharmaceuticals Showcases Data from Pain Pipeline of Medicines Designed To Deter Common Methods of Non-Therapeutic Use
06/22/2009	New Avatec® Plus 3-Nitro® Combination-Use Approval Now Brings Turkey Growers the Only Ionophore-Based Coccidiosis Control with the Performance of 3-Nitro
06/18/2009	King Pharmaceuticals to Present at Wachovia Capital Markets Conference
06/03/2009	King Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
06/01/2009	King Pharmaceuticals Appoints John J. Howarth Vice President Investor Relations
05/11/2009	King Pharmaceuticals Reports First-Quarter 2009 Financial Results
05/07/2009	King Pharmaceuticals Presents Safety, Efficacy and Measurement Data From Expanded Pain Portfolio

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next

	Documents marked with this icon are presented in Portable Document Format (PDF) to retain the original format. To view or print this document, you must use the Adobe® Acrobat® Reader®. Acrobat® Reader® is free and available directly from Adobe’s Web site with full installation instructions. You can either view and print this document or save it to your computer’s hard drive to open later. Your method may vary depending on your operating system and browser type. “Adobe” and “the Adobe logo” are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

Documents marked with this icon are presented in Portable Document Format (PDF) to retain the original format. To view or print this document, you must use the Adobe® Acrobat® Reader®. Acrobat® Reader® is free and available directly from Adobe’s Web site with full installation instructions. You can either view and print this document or save it to your computer’s hard drive to open later. Your method may vary depending on your operating system and browser type.

“Adobe” and “the Adobe logo” are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

»	Company Facts
»	Leadership
»	Annual Report
»	About Us